PMS-GALANTAMINE DIN 02333392

Status: Approved

Holder: PHARMASCIENCE INC

Molecule: GALANTAMINE (GALANTAMINE HYDROBROMIDE)

Health Canada record

Active ingredient(s)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 12 MG
Dosage form	Tablet
Route	Oral
Schedule	PRESCRIPTION
Class	Human
ATC	N06DA04 GALANTAMINE
Original market date
Current status date	26-Jan-2010
Source	Health Canada DPD

Establishment licence of the holder

Pharmascience Inc. — licence 100241, currently licensed, last inspection rating C (2025-03-20).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing GALANTAMINE (GALANTAMINE HYDROBROMIDE)

DIN	Product	Company	Form	Strength	Status
02293021	APO-GALANTAMINE	APOTEX INC	Tablet	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 4 MG	Approved
02293048	APO-GALANTAMINE	APOTEX INC	Tablet	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Approved
02293056	APO-GALANTAMINE	APOTEX INC	Tablet	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 12 MG	Approved
02425173	AURO-GALANTAMINE ER	AURO PHARMA INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 24 MG	Marketed
02425157	AURO-GALANTAMINE ER	AURO PHARMA INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Marketed
02425165	AURO-GALANTAMINE ER	AURO PHARMA INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 16 MG	Marketed
02316943	GALANTAMINE ER	ESSENTIAL PHARMA SWITZERLAND GMBH	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Marketed
02316951	GALANTAMINE ER	ESSENTIAL PHARMA SWITZERLAND GMBH	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 16 MG	Marketed
02443015	GALANTAMINE ER	SANIS HEALTH INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Marketed
02316978	GALANTAMINE ER	ESSENTIAL PHARMA SWITZERLAND GMBH	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 24 MG	Marketed
02562170	GALANTAMINE ER	SIVEM PHARMACEUTICALS ULC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 24 MG	Marketed
02562162	GALANTAMINE ER	SIVEM PHARMACEUTICALS ULC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 16 MG	Marketed
02562154	GALANTAMINE ER	SIVEM PHARMACEUTICALS ULC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Marketed
02443031	GALANTAMINE ER	SANIS HEALTH INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 24 MG	Marketed
02443023	GALANTAMINE ER	SANIS HEALTH INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 16 MG	Marketed
02419246	IPG-GALANTAMINE ER	MARCAN PHARMACEUTICALS INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 16 MG	Approved
02419254	IPG-GALANTAMINE ER	MARCAN PHARMACEUTICALS INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 24 MG	Approved
02419238	IPG-GALANTAMINE ER	MARCAN PHARMACEUTICALS INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Approved
02570947	MINT-GALANTAMINE ER	MINT PHARMACEUTICALS INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 16 MG	Approved
02570939	MINT-GALANTAMINE ER	MINT PHARMACEUTICALS INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Approved
02570955	MINT-GALANTAMINE ER	MINT PHARMACEUTICALS INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 24 MG	Approved
02339439	MYLAN-GALANTAMINE ER	MYLAN PHARMACEUTICALS ULC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Marketed
02339455	MYLAN-GALANTAMINE ER	MYLAN PHARMACEUTICALS ULC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 24 MG	Marketed
02339447	MYLAN-GALANTAMINE ER	MYLAN PHARMACEUTICALS ULC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 16 MG	Marketed
02427273	PENDO-GALANTAMINE ER	PENDOPHARM DIVISION OF PHARMASCIENCE INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Approved
02333376	PMS-GALANTAMINE	PHARMASCIENCE INC	Tablet	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 4 MG	Approved
02333384	PMS-GALANTAMINE	PHARMASCIENCE INC	Tablet	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Approved
02416603	GALANTAMINE ER	PRO DOC LIMITEE	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 24 MG	Cancelled Post Market
02416573	GALANTAMINE ER	PRO DOC LIMITEE	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Cancelled Post Market
02416581	GALANTAMINE ER	PRO DOC LIMITEE	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 16 MG	Cancelled Post Market
02420848	MAR-GALANTAMINE ER	MARCAN PHARMACEUTICALS INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 16 MG	Cancelled Post Market
02420856	MAR-GALANTAMINE ER	MARCAN PHARMACEUTICALS INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 24 MG	Cancelled Post Market
02420821	MAR-GALANTAMINE ER	MARCAN PHARMACEUTICALS INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Cancelled Post Market
02398397	PMS-GALANTAMINE ER	PHARMASCIENCE INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 24 MG	Cancelled Post Market
02398389	PMS-GALANTAMINE ER	PHARMASCIENCE INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 16 MG	Cancelled Post Market
02398370	PMS-GALANTAMINE ER	PHARMASCIENCE INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Cancelled Post Market
02270781	RATIO-GALANTAMINE	RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED	Tablet	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Cancelled Pre Market
02270773	RATIO-GALANTAMINE	RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED	Tablet	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 4 MG	Cancelled Pre Market
02270803	RATIO-GALANTAMINE	RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED	Tablet	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 12 MG	Cancelled Pre Market
02244300	REMINYL -(12MG)	JANSSEN INC	Tablet	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 12 MG	Cancelled Post Market
02244298	REMINYL -(4MG)	JANSSEN INC	Tablet	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 4 MG	Cancelled Post Market
02244299	REMINYL -(8MG)	JANSSEN INC	Tablet	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Cancelled Post Market
02266717	REMINYL ER	JANSSEN INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Cancelled Post Market
02266733	REMINYL ER	JANSSEN INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 24 MG	Cancelled Post Market
02266725	REMINYL ER	JANSSEN INC	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 16 MG	Cancelled Post Market
02392305	SANDOZ GALANTAMINE ER	SANDOZ CANADA INCORPORATED	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 24 MG	Cancelled Pre Market
02392283	SANDOZ GALANTAMINE ER	SANDOZ CANADA INCORPORATED	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Cancelled Pre Market
02392291	SANDOZ GALANTAMINE ER	SANDOZ CANADA INCORPORATED	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 16 MG	Cancelled Pre Market
02377969	TEVA-GALANTAMINE ER	TEVA CANADA LIMITED	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 16 MG	Cancelled Post Market
02377950	TEVA-GALANTAMINE ER	TEVA CANADA LIMITED	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 8 MG	Cancelled Post Market
02377977	TEVA-GALANTAMINE ER	TEVA CANADA LIMITED	Capsule (Extended-Release)	GALANTAMINE (GALANTAMINE HYDROBROMIDE) 24 MG	Cancelled Post Market

Notices of Compliance

NOC	Date	Submission	Reason
10968	2010-01-26	Abbreviated New Drug Submission (ANDS)	New manufacturer and product name

Request a quote for PMS-GALANTAMINE

How to read a Canadian DIN record